Jeff Stoll

He has over 15 years of experience providing strategy consulting services to the biopharmaceutical industry and equity clients interested in life science sector acquisitions. He specializes in supporting clients across the inorganic growth continuum from portfolio strategy to commercial due diligence to integration strategy. Jeff and his team have averaged thirty deals per year between strategic and equity clients for the past six years. Prior to starting his consulting career, Jeff was an Assistant Professor at the University of Florida with an appointment at Shands Hospital, where he specialized in solid organ transplant.